Alkem Laboratories schedules meeting with SBI Mutual Fund
Alkem Laboratories Limited has informed the stock exchanges about a scheduled interaction with SBI Mutual Fund. The meeting is set to take place on May 29, 2026, in Mumbai, under the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
*this image is generated using AI for illustrative purposes only.
Alkem Laboratories Limited has scheduled a one-on-one meeting with SBI Mutual Fund on May 29, 2026, in Mumbai. The interaction aims to engage with the institutional investor regarding the company's operations and performance.
The disclosure was made in reference to the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company specified that the engagement will be an in-person meeting.
Meeting Details
The following table outlines the specifics of the scheduled interaction:
| Date | Analyst / Investor | Type of Meeting | Nature of Meeting | Location |
|---|---|---|---|---|
| May 29, 2026 | SBI Mutual Fund | In-person | One-on-One meet | Mumbai |
The company noted that the schedule for the aforementioned meeting is subject to change due to exigencies on the part of the investor or the company. The intimation was signed by Manish Narang, President – Legal, Company Secretary & Compliance Officer.
Historical Stock Returns for Alkem Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.85% | +1.13% | +2.88% | -3.31% | +4.41% | +87.36% |
What key operational updates is Alkem Laboratories likely to discuss with SBI Mutual Fund?
How might this engagement influence SBI Mutual Fund's investment stance on Alkem Laboratories?
Could this meeting signal upcoming strategic shifts or new growth initiatives for Alkem?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
